Literature DB >> 29718228

Revealing the Puzzle of Nonadherence in IBD-Assembling the Pieces.

Adi Eindor-Abarbanel1, Timna Naftali2, Nahum Ruhimovich2, Ariella Bar-Gil Shitrit3, Fabiana Sklerovsky-Benjaminov2, Fred Konikoff2, Shai Matalon1, Haim Shirin1, Yael Milgrom3, Efrat Broide1.   

Abstract

Background: Adherence is generally associated with improved treatment outcomes in inflammatory bowel disease (IBD) patients. Different components of the patient profile have an impact on patient adherence. Capturing nonadherent patients by identifying modifiable risk factors in daily practice still remains a challenge. The objective of this study was to identify modifiable and nonmodifiable risk factors for nonadherence in IBD patients.
Methods: Patients filled out questionnaires including demographic, clinical, and socioeconomic information and accessibility to gastrointestinal services. Psychological features were assessed using the Sense of Coherence, Hospital Anxiety and Depression Scale, IBD-Self Efficacy, and Brief Illness Perception (BIPQ) questionnaires. Adherence to treatment was evaluated using the Morisky score.
Results: The study included 311 patients: 62.4% females, median age 34.78 years, 70.4% Crohn's disease (CD). Multivariate analysis was done in 3 sections: demographic and disease characteristics, communication with medical staff, and psychological aspects; all included sex and disease type. Ulcerative colitis (UC) patients were less adherent (odds ratio [OR], 1.792; OR, 1.915; OR, 1.748; respectively). Females were less adherent in 2 sections (OR, 1.841; OR, 1.751; respectively). Employment (OR, 2.449), low score in on the BIPQ-understanding of disease (OR, 0.881), and poor communication with the gastroenterologist (OR, 1.798) were also predictors of low adherence. Conclusions: Nonmodifiable characteristics such as female sex and UC are associated with low adherence. Good communication with the treating physician and understanding the disease are modifiable factors associated with high adherence. Early intervention might improve patients' adherence.

Entities:  

Mesh:

Year:  2018        PMID: 29718228     DOI: 10.1093/ibd/izy013

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  2 in total

1.  Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients.

Authors:  Wen Hu; Shurong Hu; Yimiao Zhu; Hanwen Chen; Yan Chen
Journal:  Patient Prefer Adherence       Date:  2020-07-02       Impact factor: 2.711

2.  Utility of the MARS-5 in Assessing Medication Adherence in IBD.

Authors:  James K Stone; Leigh Anne Shafer; Lesley A Graff; Lisa Lix; Kelcie Witges; Laura E Targownik; Clove Haviva; Kathryn Sexton; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.